biospecimen_aliquot__bcr_aliquot_barcode	tcga-ol-a5rw-01a-11d-a28b-09
biospecimen_aliquot__bcr_aliquot_uuid	8e4c566c-99f9-4ca5-a8df-c2535130630a
biospecimen_aliquot__bcr_patient_uuid	a82d0a57-4383-473d-b334-d13b278404b1
biospecimen_aliquot__bcr_sample_barcode	tcga-ol-a5rw-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0132159632
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.07
biospecimen_aliquot__date_of_shipment	2013-04-17
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	3
biospecimen_aliquot__plate_id	a28b
biospecimen_aliquot__plate_row	c
biospecimen_aliquot__quantity	2.80
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	40.00
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-ol-a5rw-01a-11d
biospecimen_analyte__bcr_analyte_uuid	ae117c26-5210-441a-8acc-c2375eb76df5
biospecimen_analyte__bcr_patient_uuid	a82d0a57-4383-473d-b334-d13b278404b1
biospecimen_analyte__bcr_sample_barcode	tcga-ol-a5rw-01a
biospecimen_analyte__concentration	0.15
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	picogreen
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-ol-a5rw
biospecimen_diagnostic_slides__bcr_patient_uuid	a82d0a57-4383-473d-b334-d13b278404b1
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-ol-a5rw-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	e16de8ee-31af-4eaf-a85f-db3e3e2c3bff
biospecimen_normal_control__bcr_patient_barcode	tcga-ol-a5rw
biospecimen_normal_control__bcr_patient_uuid	a82d0a57-4383-473d-b334-d13b278404b1
biospecimen_normal_control__ncedna_dna_conc	0.107
biospecimen_normal_control__ncedna_dna_qm	picogreen
biospecimen_normal_control__ncedna_dna_qty	15
biospecimen_normal_control__ncedna_dna_vol	140
biospecimen_portion__bcr_patient_uuid	a82d0a57-4383-473d-b334-d13b278404b1
biospecimen_portion__bcr_portion_barcode	tcga-ol-a5rw-01a-11
biospecimen_portion__bcr_portion_uuid	8130d77d-9def-49f7-9584-255f08304bc7
biospecimen_portion__bcr_sample_barcode	tcga-ol-a5rw-01a
biospecimen_portion__date_of_creation	2013-02-19
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	11
biospecimen_portion__portion_sequence	1
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-ol-a5rw-01a-11d
biospecimen_protocol__bcr_patient_uuid	a82d0a57-4383-473d-b334-d13b278404b1
biospecimen_protocol__bcr_sample_barcode	tcga-ol-a5rw-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	a82d0a57-4383-473d-b334-d13b278404b1
biospecimen_sample__bcr_sample_barcode	tcga-ol-a5rw-01a
biospecimen_sample__bcr_sample_uuid	b280103f-8732-4ee4-9e61-357a9cb3a0a9
biospecimen_sample__days_to_collection	771
biospecimen_sample__initial_weight	240
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	true
biospecimen_sample__pathology_report_file_name	tcga-ol-a5rw.86b06754-b000-4f8b-9037-95e7a0bd4d20.pdf
biospecimen_sample__pathology_report_uuid	86b06754-b000-4f8b-9037-95e7a0bd4d20
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	a82d0a57-4383-473d-b334-d13b278404b1
biospecimen_shipment_portion__bcr_sample_barcode	tcga-ol-a5rw-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	e1d1d1cd-4b4d-4cfe-86b8-7dfe9ca08c75
biospecimen_shipment_portion__center_id	20
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a321
biospecimen_shipment_portion__portion_number	21
biospecimen_shipment_portion__portion_sequence	2
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-ol-a5rw-01a-21-a321-20
biospecimen_shipment_portion__shipment_portion_day_of_shipment	16
biospecimen_shipment_portion__shipment_portion_month_of_shipment	9
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2013
biospecimen_slide__bcr_patient_uuid	a82d0a57-4383-473d-b334-d13b278404b1
biospecimen_slide__bcr_sample_barcode	tcga-ol-a5rw-01a
biospecimen_slide__bcr_slide_barcode	tcga-ol-a5rw-01a-01-ts1
biospecimen_slide__bcr_slide_uuid	4a172d57-5f02-4680-8106-81459fc20b26
biospecimen_slide__image_file_name	tcga-ol-a5rw-01a-01-ts1.4a172d57-5f02-4680-8106-81459fc20b26.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	5
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	2
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	0
biospecimen_slide__percent_stromal_cells	53
biospecimen_slide__percent_tumor_cells	45
biospecimen_slide__percent_tumor_nuclei	80
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-ol-a5rw
biospecimen_tumor_sample__bcr_patient_uuid	a82d0a57-4383-473d-b334-d13b278404b1
clinical_drug__bcr_drug_barcode	tcga-ol-a5rw-d65259
clinical_drug__bcr_drug_uuid	b981af2a-14cd-4f9e-b7f0-e4097ac4a18c
clinical_drug__bcr_patient_barcode	tcga-ol-a5rw
clinical_drug__bcr_patient_uuid	a82d0a57-4383-473d-b334-d13b278404b1
clinical_drug__form_completion_date	2014-9-24
clinical_drug__pharmaceutical_therapy_drug_name	adriamycin
clinical_drug__pharmaceutical_therapy_type	chemotherapy
clinical_drug__pharmaceutical_tx_ended_days_to	234
clinical_drug__pharmaceutical_tx_ongoing_indicator	no
clinical_drug__pharmaceutical_tx_started_days_to	69
clinical_drug__treatment_best_response	complete response
clinical_drug__tx_on_clinical_trial	no
clinical_follow_up__bcr_followup_barcode	tcga-ol-a5rw-f56568
clinical_follow_up__bcr_followup_uuid	51fa5005-5700-4bb5-8303-4369c6d86e8d
clinical_follow_up__bcr_patient_barcode	tcga-ol-a5rw
clinical_follow_up__bcr_patient_uuid	a82d0a57-4383-473d-b334-d13b278404b1
clinical_follow_up__followup_lost_to	no
clinical_follow_up__form_completion_date	2014-2-14
clinical_follow_up__last_contact_days_to	1106
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__pharmaceutical_tx_adjuvant	yes
clinical_follow_up__radiation_treatment_adjuvant	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_patient__age_at_diagnosis	40
clinical_patient__ajcc_metastasis_pathologic_pm	mx
clinical_patient__ajcc_nodes_pathologic_pn	n1
clinical_patient__ajcc_pathologic_tumor_stage	stage iia
clinical_patient__ajcc_staging_edition	7th
clinical_patient__ajcc_tumor_pathologic_pt	t1c
clinical_patient__anatomic_neoplasm_subdivision	right upper outer quadrant
clinical_patient__axillary_staging_method	sentinel lymph node biopsy plus axillary dissection
clinical_patient__bcr_patient_barcode	tcga-ol-a5rw
clinical_patient__bcr_patient_uuid	a82d0a57-4383-473d-b334-d13b278404b1
clinical_patient__birth_days_to	-14638
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_status_by_ihc	negative
clinical_patient__form_completion_date	2013-5-16
clinical_patient__gender	female
clinical_patient__her2_cent17_ratio	1.91
clinical_patient__her2_fish_status	negative
clinical_patient__histological_type	infiltrating ductal carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8500/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2010
clinical_patient__last_contact_days_to	797
clinical_patient__lymph_nodes_examined	yes
clinical_patient__lymph_nodes_examined_count	4
clinical_patient__lymph_nodes_examined_he_count	1
clinical_patient__margin_status	negative
clinical_patient__menopause_status	pre (<6 months since lmp and no prior bilateral ovariectomy and not on estrogen replacement)
clinical_patient__method_initial_path_dx	excisional biopsy
clinical_patient__new_tumor_event_dx_indicator	no
clinical_patient__patient_id	a5rw
clinical_patient__pharmaceutical_tx_adjuvant	yes
clinical_patient__pr_status_by_ihc	negative
clinical_patient__prospective_collection	no
clinical_patient__race	black or african american
clinical_patient__radiation_treatment_adjuvant	yes
clinical_patient__retrospective_collection	yes
clinical_patient__surgical_procedure_first	lumpectomy
clinical_patient__tissue_source_site	ol
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
clinical_radiation__bcr_patient_barcode	tcga-ol-a5rw
clinical_radiation__bcr_patient_uuid	a82d0a57-4383-473d-b334-d13b278404b1
clinical_radiation__bcr_radiation_barcode	tcga-ol-a5rw-r65258
clinical_radiation__bcr_radiation_uuid	fe53aba6-9490-4966-8236-991863c30a5d
clinical_radiation__form_completion_date	2014-9-24
clinical_radiation__radiation_adjuvant_units	cgy
clinical_radiation__radiation_therapy_ended_days_to	234
clinical_radiation__radiation_therapy_ongoing_indicator	no
clinical_radiation__radiation_therapy_site	primary tumor field
clinical_radiation__radiation_therapy_started_days_to	184
clinical_radiation__radiation_therapy_type	external
clinical_radiation__radiation_total_dose	5040
clinical_radiation__treatment_best_response	complete response
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-OL-A5RW-01A-11D-A28B-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-OL-A5RW-01A-11D-A28B-09.bed.meta
manually_curated__id	tcga-ol-a5rw-01a-11d-a28b-09
manually_curated__md5sum	03177b57d13041682acf072cd7ae0de8
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	8e4c566c-99f9-4ca5-a8df-c2535130630a
manually_curated__tumor_tag	brca
